| Literature DB >> 17317170 |
Lauren Monovich1, Benjamin Mugrage, Elizabeth Quadros, Karen Toscano, Ruben Tommasi, Stacey LaVoie, Eugene Liu, Zhengming Du, Daniel LaSala, William Boyar, Paul Steed.
Abstract
Halopemide, which was identified by HTS to inhibit phospholipase D2 (PLD2), provided the basis for an exploratory effort to identify potent inhibitors of PLD2 for use as inflammatory mediators. Parallel synthesis and purification were utilized to rapidly identify orally available amide analogs derived from indole 2-carboxylic acids with superior potency versus PLD2.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17317170 DOI: 10.1016/j.bmcl.2007.01.059
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823